BIOMARKERS FOR DIAGNOSIS, PROGNOSIS, PREVENTION, IMPROVEMENT OR RELIEF IN THE TREATMENT OF CHILDHOOD B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

Patent number:

WO22129668

No items found.

The present invention describes the use of lncRNA AL133346.1, optionally combined with mRNAs, for the diagnosis, prognosis, prevention, improvement, relief or treatment of childhood B-cell acute lymphoblastic leukemia, and methods, kits and devices based on said use.

Countries:

Spain

Regions:

Andalusia

Centers:

UNIVERSIDAD DE GRANADA

Other entities:

Sectors:

Health

Subsectors:

Biotechnology

TRL Level:

TRL 2 – technology concept formulated

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

Applications

Use of lncRNA and mRNA as diagnostic biomarkers for pediatric B-ALL. Support in the therapeutic strategy of patients with pediatric B-ALL. No specific equipment is necessary. Simple method.

Comments

Other related patents

Health

New & Sustainable Materials

Other

PREPARATION, COMPOSITION AND APPLICATION OF A BIOACTIVE FLUORIDE-DOPED CALCIUM PHOSPHATE ABLE TO INDUCED CONTROLLED DEPOSITION OF FLUORAPATITE

Countries

Spain

Health

TISSUE ELASTICITY MEASUREMENT

Countries

Belgium

Food & Agro

Health

VOLATILE ORGANIC COMPOUND CHAMBER (VOC CHAMBER) FOR THE PERFORMANCE OF MICROBIOLOGICAL VOLATILE INTERACTION ASSAYS

Countries

Spain

Get back to patents directory